110 related articles for article (PubMed ID: 10726379)
1. [Antineutrophil cytoplasmic antibodies (ANCA) in chronic inflammatory intestinal disease].
García Herola A; Nos Mateu P; Ponce García J
Gastroenterol Hepatol; 2000 Jan; 23(1):16-23. PubMed ID: 10726379
[No Abstract] [Full Text] [Related]
2. Serum antibodies for the diagnosis of inflammatory bowel disease: ANCA for ulcerative colitis and ASCA for Crohn's disease.
Tecnologica MAP Suppl; 1999 Jun; ():18-20. PubMed ID: 10848041
[No Abstract] [Full Text] [Related]
3. [Physiopathology of inflammatory bowel diseases: new biological tools for disease diagnosis and monitoring?].
Desreumaux P; Bourreille A; Colombel JF
Gastroenterol Clin Biol; 2003 Mar; 27(3 Suppl):S81-6. PubMed ID: 12704300
[No Abstract] [Full Text] [Related]
4. Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies: serologic markers in inflammatory bowel disease.
Hartman C; Eliakim R; Shamir R
Isr Med Assoc J; 2004 Apr; 6(4):221-6. PubMed ID: 15115261
[No Abstract] [Full Text] [Related]
5. [Role of perinuclear antibodies against cytoplasm of neutrophilic granulocytes (p-ANCA) in the diagnosis of vasculitis and chronic inflammatory diseases].
Oudkerk Pool M
Ned Tijdschr Geneeskd; 1997 Jan; 141(1):63-4. PubMed ID: 9162858
[No Abstract] [Full Text] [Related]
6. Serological markers (anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic antibodies) in inflammatory bowel disease: diagnostic utility and phenotypic correlation.
Buckland MS; Mylonaki M; Rampton D; Longhurst HJ
Clin Diagn Lab Immunol; 2005 Nov; 12(11):1328-30. PubMed ID: 16275949
[TBL] [Abstract][Full Text] [Related]
7. The value of serological and genetic markers in inflammatory bowel disease; strength and weakness of the studies.
Peña AS
Rev Esp Enferm Dig; 2003 Nov; 95(11):752-4, 749-51. PubMed ID: 14640872
[No Abstract] [Full Text] [Related]
8. Immunological markers anti-saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: a helpful diagnostic tool.
Montanelli A; Mainardi E; Vagni A; Villanacci V; Zambelli C; Cestari R; Cengia P; Minelli L; Missale G
Minerva Gastroenterol Dietol; 2005 Jun; 51(2):201-7. PubMed ID: 15990710
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a multiplex flow cytometric immunoassay to detect PR3- and MPO-ANCA in active and treated vasculitis, and in inflammatory bowel disease (IBD).
Trevisin M; Pollock W; Dimech W; Savige J
J Immunol Methods; 2008 Jul; 336(2):104-12. PubMed ID: 18499121
[TBL] [Abstract][Full Text] [Related]
10. [Antineutrophil cytoplasmatic antibodies and their diagnostic significance as serum markers].
Terjung B; Spengler U; Sauerbruch T
Dtsch Med Wochenschr; 1999 Nov; 124(44):1314-20. PubMed ID: 10596294
[No Abstract] [Full Text] [Related]
11. Positive and negative predictive values: use of inflammatory bowel disease serologic markers.
Austin GL; Shaheen NJ; Sandler RS
Am J Gastroenterol; 2006 Mar; 101(3):413-6. PubMed ID: 16542272
[No Abstract] [Full Text] [Related]
12. Antineutrophil cytoplasmic autoantibodies-antigen specificity and associated diseases.
Vizjak A; Nagode B; Rott T; Koselj M; Rozman B; Kaplan-Pavlovcic S; Kosnik M; Petric V; Ferluga D
Wien Klin Wochenschr; 2000 Aug; 112(15-16):665-70. PubMed ID: 11020953
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic tools in inflammatory bowel diseases].
Bouhnik Y
Rev Prat; 2005 May; 55(9):977-83. PubMed ID: 16052968
[TBL] [Abstract][Full Text] [Related]
14. [Differential diagnosis of chronic inflammatory bowel diseases. Value of determination of autoantibodies pANCA, ASCA AND PAB (perinuclear antineutrophil cytoplasmic antibody, antibody against Saccharomyces cerevisiae, antibody against pancreas)].
Seibold F; Hufnagl R; Scheurlen M
Fortschr Med; 1999 Feb; 117(6):42-3. PubMed ID: 10095303
[No Abstract] [Full Text] [Related]
15. Distinguishing between anti-neutrophil cytoplasmic antibody patterns in inflammatory bowel disease: is the "atypical pattern" adding more information?
Barahona-Garrido J; Hernández-Calleros J; Cabiedes J; Sarti HM; Torre A; Montaño-Loza AJ; Yamamoto-Furusho JK
Am J Gastroenterol; 2009 Jul; 104(7):1854-5. PubMed ID: 19574983
[No Abstract] [Full Text] [Related]
16. Diagnostic value of serological assays in pediatric inflammatory bowel disorders.
Mainardi E; Villanacci V; Bassotti G; Liserre B; Rossi E; Incardona P; Falchetti D; Tonegatti L; Montanelli A; Barabino A; Coccia C; Gambini C
Digestion; 2007; 75(4):210-4. PubMed ID: 17952008
[TBL] [Abstract][Full Text] [Related]
17. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease.
Caradonna L; Amati L; Lella P; Jirillo E; Caccavo D
Am J Gastroenterol; 2000 Jun; 95(6):1495-502. PubMed ID: 10894586
[TBL] [Abstract][Full Text] [Related]
18. Serological diagnosis of inflammatory bowel disease.
Rutgeerts P; Vermeire S
Lancet; 2000 Dec 23-30; 356(9248):2117-8. PubMed ID: 11191535
[No Abstract] [Full Text] [Related]
19. Bactericidal/permeability-increasing protein antineutrophil cytoplasmic antibodies (ANCA) and associated diseases: clinical relevance of an emerging ANCA target antigen.
Emmi L; Chatzipetrou A
Ann Ital Med Int; 2005; 20(4):205-8. PubMed ID: 16610250
[No Abstract] [Full Text] [Related]
20. Serologic markers in inflammatory bowel disease (IBD).
Nakamura RM; Barry M
MLO Med Lab Obs; 2001 Nov; 33(11):8-15; quiz 16-9. PubMed ID: 11721286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
